» Articles » PMID: 22234979

The Brain--gut Pathway in Functional Gastrointestinal Disorders is Bidirectional: a 12-year Prospective Population-based Study

Overview
Journal Gut
Specialty Gastroenterology
Date 2012 Jan 12
PMID 22234979
Citations 199
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Psychological factors are known to be associated with functional gastrointestinal disorders (FGIDs) including irritable bowel syndrome (IBS) and functional dyspepsia (FD). No prospective studies have evaluated whether it is the brain (eg, via anxiety) that drives gut symptoms, or whether gut dysfunction precipitates the central nervous system features such as anxiety. In a 12-year longitudinal, prospective, population-based study, we aimed to determine the directionality of the brain-gut mechanism in FGIDs.

Design: Participants (n=1775) were a random population sample from Australia who responded to a survey on FGIDs in 1997 and agreed to be contacted for future research; 1002 completed the 12-year follow-up survey (response rate =60%), with 217, 82 and 45 people meeting Rome II for new onset FGIDs, IBS and FD, respectively. Anxiety and depression were measured using the Delusions Symptom States Inventory at baseline and follow-up.

Results: Among people free of a FGID at baseline, higher levels of anxiety (OR 1.11; 95% CI 1.03 to 1.19, p=0.006) but not depression at baseline was a significant independent predictor of developing new onset FGIDs 12 years later. Among people who did not have elevated levels of anxiety and depression at baseline, those with a FGID at baseline had significantly higher levels of anxiety and depression at follow-up (mean difference coefficient 0.76, p<0.001 and 0.30, p=0.01 for anxiety and depression, respectively). In IBS higher levels of anxiety and depression at baseline were predictive of IBS at follow-up, while only depression was predictive of FD at follow-up.

Conclusions: The central nervous system and gut interact bidirectionally in FGIDs.

Citing Articles

Role of Peripheral NLRP3 Inflammasome in Cognitive Impairments: Insights of Non-central Factors.

Qiao M, Ni J, Qing H, Qiu Y, Quan Z Mol Neurobiol. 2025; .

PMID: 40000575 DOI: 10.1007/s12035-025-04779-8.


Brain activity during a public-speaking situation in virtual reality in patients with irritable bowel syndrome and functional dyspepsia.

Katsumata R, Hosokawa T, Manabe N, Mori H, Wani K, Kimura M J Gastroenterol. 2025; .

PMID: 39994039 DOI: 10.1007/s00535-025-02228-w.


Association of anxiety status and anxiety duration with constipation in adult Americans: a cross-sectional study using data from the NHANES 2007-2010.

Li X, Bian C, Dai H, Chen X, Qian H, Zhang D BMC Gastroenterol. 2025; 25(1):31.

PMID: 39844049 PMC: 11756022. DOI: 10.1186/s12876-024-03575-3.


A Standardized Classification Scheme for Gastroduodenal Disorder Evaluation Using the Gastric Alimetry System: Prospective Cohort Study.

Varghese C, Schamberg G, Uren E, Calder S, Law M, Foong D Gastro Hep Adv. 2025; 4(1):100547.

PMID: 39802489 PMC: 11719321. DOI: 10.1016/j.gastha.2024.09.002.


Toll-like receptor 4 plays a vital role in irritable bowel syndrome: a scoping review.

Wan X, Wang L, Wang Z, Wan C Front Immunol. 2025; 15:1490653.

PMID: 39749341 PMC: 11693509. DOI: 10.3389/fimmu.2024.1490653.